MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine MOUNTAIN VIEW, Calif., Jan 16, 2008 -- MAP Pharmaceuticals, ...
Lung Cancer Master Protocol (Lung-MAP), a public-private partnership, established infrastructure for conducting a biomarker-driven master protocol in molecularly targeted therapies. We compared ...
As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of ...
Neurons generated from stem cells (from skin fibroblasts) of a patient with sporadic Alzheimer’s disease. Visualized with a specific green fluorescent marker. Nuclei are shown in blue. Researchers ...
A prototype service utilising satellites for mapping forests to aid compliance with the Kyoto Protocol has been endorsed by end users from European countries one environmental ministry representative ...
The continuous generation of increasingly large-scale data sets in systems biology results in an urgent need for better visualizations of complex and interweaved biological data in the form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results